The success of GLP-1 medications has reduced the use of bariatric surgery for major weight loss by 140%, according to a Harvard University School of Public Health study of insurance claims from 2022-2024
Am J Med Genet C 142C:7785 Szabo K, Nagy Z, Juhasz V, Zolnerciks JK, Csorba A, Timar Z, Molnar E, Padar P, Johnson W, Beery E, Krajcsi P (2016) Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2)
Ans: Keep LiquiCarn at room temperature and out of direct sunlight so it stays effective
Approval is not expected until mid-2026 or 2027 at the earliest
Thats why InjectCo starts every California patients experience with an online evaluation to gather the right context before making recommendations